Table I.
Clinicopathological features of tamoxifen-resistant patients (n=122).
| Parameters | No. (%) |
|---|---|
| Age (years) | |
| <30 | 3 (2.5) |
| 30-40 | 36 (29.5) |
| 40-50 | 69 (56.6) |
| ≥50 | 14 (11.4) |
| Time of metastasis (months) | |
| <24 | 59 (48.4) |
| ≥24 | 63 (51.6) |
| Surgical procedure | |
| Mastectomy | 103 (84.4) |
| Breast-conserving | 19 (15.6) |
| Subtypes of Cancer | |
| Ductal | 115 (94.4) |
| Lobular | 4 (3.2) |
| Others | 3 (2.4) |
| TNM staging | |
| I | 10 (8.2) |
| IIA | 29 (23.8) |
| IIB | 42 (34.4) |
| IIIA | 21 (17.2) |
| IIIB | 10 (8.2) |
| IIIC | 2 (1.6) |
| Unknown | 8 (6.6) |
| Recurrent or/and metastatic site | |
| Breast | 9 (7.4) |
| Chest wall | 27 (22.1) |
| Lymph nodea | 21 (17.2) |
| Boneb | 26 (21.3) |
| Brainc | 3 (2.5) |
| Liverc | 13 (10.7) |
| Lungc | 16 (13.1) |
| Multi-visceral metastasisd | 7 (5.7) |
a
Irrespective of the local situation;
b
irrespective of the local situation and lymph node;
c
irrespective of the local situation, lymph node and bone;
d
including two parts of lung, liver and brain.